Documente Academic
Documente Profesional
Documente Cultură
Oana Grinei
Medic rezident Medicina Interna anul I
Coordonator tiinific: Conf. Dr. Andra Blnescu
Introducere
-mortalitatea la 30 de zile
Patient years,
18 113 24 851 4082 1976 4950
sum
Age, years,
57.6 (12.3) 54.9 (12.6) 56.7 (12.8) 58.1 (12.9) 58.7 (12.1)
mean (SD)
Disease
duration,
7.2 (8.0) 10.7 (9.2) 10.6 (8.7) 12.0 (9.0) 13.8 (9.9)
years, mean
(SD)
No. of
previous
1.4 (0.9) 2.7 (1.4) 2.2 (1.1) 2.4 (1.3) 2.6 (1.2)
csDMARDs,
mean (SD)
Diverticulosis/
prior 12 (0.3) 11 (0.2) 3 (0.3) 4 (1.1) 5 (0.5)
diverticulitis
Gastrointestin
159 (3.6) 339 (5.1) 43 (4.9) 26 (7.0) 59 (6.4)
al diseases
Rezultate
11 13 11 1 1
N
Average over 6 months, mean (SD) 5.6 (3.8) 9.7 (9.3) 7.5 (7.5) [5.0] [10.0]
Average over 12 months, mean 5.6 (3.4) 9.6 (9.0) 8.1 (7.3) [5.0] [10.0]
(SD)
Tabel III. Indici de risc i rezultatele regresiilor Cox
multivariate.
Multiple Multiple
Univariate
Cox regression 1 Cox regression 2
(2.01 to
Tocilizumab 4.17 (1.87 to 9.27) 5.11 (2.31 to 11.3) 4.48
9.99)
GCs
Current GC (by
1.22 (1.13 to 1.31) 1.28 (1.18 to 1.38)
5 mg)
(1.50 to
Cumulative GCs* 1.81 (1.47 to 2.22) 1.87
2.33)
NSAIDs
Cumulative (1.33 to
2.71 (1.20 to 6.12) 3.00
NSAIDs 6.82)
Tabel IV. Incidenele diverticulitelor, perforaiilor,
perforaiilor letale.
Total no. of diverticulitis
csDMARDs 18 113 34 (1.9 (1.3 to 2.6)) 11 (32.4 (17.4 to 50.5)) 1 (9.1 (0.0 to 41.3))
13 (35.1 (20.2 to
TNFi 24 851 37 (1.5 (1.1 to 2.1)) 3 (23.1 (5.0 to 53.8))
52.5))
Tocilizumab 4082 16 (3.9 (2.2 to 6.4)) 11 (68.7 (41.3 to 89.0)) 5 (45.5 (16.8 to 76.6))
Total 53 972 92 (1.7 (1.4 to 2.1)) 37 (40.2 (30.1 to 31.0)) 9 (24.3 (11.8 to 41.2))
Discuii
Pacienii tratai cu TCZ - simptomatologie redus (durere abdominal
acut: 90% csDMARDS, 60% TNFi, 27% TCZ)